These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 11394888)

  • 1. Hepatic expression of SV40 small-T antigen blocks the in vivo CD95-mediated apoptosis.
    Gillet R; Cavard C; Grimber G; Briand P; Joulin V
    Biochem Biophys Res Commun; 2001 Jun; 284(2):369-76. PubMed ID: 11394888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-dependent apoptosis is impaired by SV40 T-antigen in transgenic liver.
    Rouquet N; Allemand I; Molina T; Bennoun M; Briand P; Joulin V
    Oncogene; 1995 Sep; 11(6):1061-7. PubMed ID: 7566965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.
    Terradillos O; de La Coste A; Pollicino T; Neuveut C; Sitterlin D; Lecoeur H; Gougeon ML; Kahn A; Buendia MA
    Oncogene; 2002 Jan; 21(3):377-86. PubMed ID: 11821950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of hepatocyte proliferation and death by modulation of T-Antigen expression.
    Comerford SA; Clouthier DE; Hinnant EA; Hammer RE
    Oncogene; 2003 Apr; 22(16):2515-30. PubMed ID: 12717428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
    Moriyama H; Yonehara S
    Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of faim reveals its role in modulating c-FLIP expression during CD95-mediated apoptosis of lymphocytes and hepatocytes.
    Huo J; Xu S; Guo K; Zeng Q; Lam KP
    Cell Death Differ; 2009 Jul; 16(7):1062-70. PubMed ID: 19300454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
    Portis T; Longnecker R
    Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of AKT-regulated genes in inducible MERAkt cells.
    Kuhn I; Bartholdi MF; Salamon H; Feldman RI; Roth RA; Johnson PH
    Physiol Genomics; 2001 Dec; 7(2):105-14. PubMed ID: 11773597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compensatory apoptosis in response to SV40 large T antigen expression in the liver.
    Allemand I; Grimber G; Kornprobst M; Bennoun M; Molina T; Briand P; Joulin V
    Oncogene; 1995 Dec; 11(12):2583-90. PubMed ID: 8545115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice.
    Bennoun M; Grimber G; Couton D; Seye A; Molina T; Briand P; Joulin V
    Oncogene; 1998 Sep; 17(10):1253-9. PubMed ID: 9771968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice.
    de Coupade C; Gillet R; Bennoun M; Briand P; Russo-Marie F; Solito E
    Hepatology; 2000 Feb; 31(2):371-80. PubMed ID: 10655260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes.
    Amicone L; Spagnoli FM; Späth G; Giordano S; Tommasini C; Bernardini S; De Luca V; Della Rocca C; Weiss MC; Comoglio PM; Tripodi M
    EMBO J; 1997 Feb; 16(3):495-503. PubMed ID: 9034332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice.
    Martin DC; Rüther U; Sanchez-Sweatman OH; Orr FW; Khokha R
    Oncogene; 1996 Aug; 13(3):569-76. PubMed ID: 8760297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SV40 rodent tumour models as paradigms of human disease: transgenic mouse models.
    Furth PA
    Dev Biol Stand; 1998; 94():281-7. PubMed ID: 9776248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of lens tumors, liver and spleen in α-crystallin/SV40 T antigen transgenic mice treated with Juzen-taiho-to.
    Zheng HC; Noguchi A; Kikuchi K; Ando T; Nakamura T; Takano Y
    Mol Med Rep; 2014 Feb; 9(2):547-52. PubMed ID: 24337676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of hepatocytes from Fas-mediated apoptosis by a non-transforming SV40 T-antigen mutant.
    Rouquet N; Allemand I; Grimber G; Molina T; Briand P; Joulin V
    Cell Death Differ; 1996 Jan; 3(1):91-6. PubMed ID: 17180059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-fos and c-myc protooncogenes in an immortalized hepatocyte line harbouring SV40 T antigen and hGH as transgenes.
    Hirsch-Ernst KI; Paul D; Kahl GF; Höhne MW
    Transgenic Res; 1993 Mar; 2(2):101-8. PubMed ID: 8513338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.